Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Managing drug interactions in HIV-infected adults with comorbid illness
Christine Hughes, Alice Tseng, Ryan Cooper
Canadian Medical Association Journal (2014) Vol. 187, Iss. 1, pp. 36-43
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Impact of gastrointestinal physiology on drug absorption in special populations––An UNGAP review
Cordula Stillhart, Katarina Vučićević, Patrick Augustijns, et al.
European Journal of Pharmaceutical Sciences (2020) Vol. 147, pp. 105280-105280
Open Access | Times Cited: 219
CD8+ T-Cell Response to HIV Infection in the Era of Antiretroviral Therapy
Federico Perdomo-Celis, Natalia A. Taborda, Marı́a Teresa Rugeles
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 76
Cardiovascular Drug Interactions With Nirmatrelvir/Ritonavir in Patients With COVID-19
Sonu Abraham, Anju Nohria, Tomas G. Neilan, et al.
Journal of the American College of Cardiology (2022) Vol. 80, Iss. 20, pp. 1912-1924
Open Access | Times Cited: 38
Midazolam: an essential palliative care drug
Eric Prommer
Palliative Care and Social Practice (2020) Vol. 14
Open Access | Times Cited: 65
DeepARV: ensemble deep learning to predict drug-drug interaction of clinical relevance with antiretroviral therapy
Thao Pham, Mohamed Ghafoor, Sandra Grañana‐Castillo, et al.
npj Systems Biology and Applications (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Polypharmacy in HIV: recent insights and future directions
E. Jennifer Edelman, Christopher T. Rentsch, Amy C. Justice
Current Opinion in HIV and AIDS (2019) Vol. 15, Iss. 2, pp. 126-133
Open Access | Times Cited: 54
The Impact of Non-Antiretroviral Polypharmacy on the Continuity of Antiretroviral Therapy (ART) Among HIV Patients
Hartmut B. Krentz, M. John Gill
AIDS Patient Care and STDs (2015) Vol. 30, Iss. 1, pp. 11-17
Closed Access | Times Cited: 49
Prevalence and Associated Factors of Treatment Regimen Fatigue Among People Living with HIV/AIDS in China: A Cross-Sectional Survey
Baohua Liu, Yisi Yang, Hongguo Zhou, et al.
Patient Preference and Adherence (2025) Vol. Volume 19, pp. 583-591
Open Access
Clinically Relevant Interactions between Atypical Antipsychotics and Anti-Infective Agents
Edoardo Spina, María Antonietta Barbieri, Giuseppe Cicala, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 12, pp. 439-439
Open Access | Times Cited: 30
Eosinophilic Esophagitis—What Do We Know So Far?
Jakub Wąsik, Ewa Małecka‐Panas
Journal of Clinical Medicine (2023) Vol. 12, Iss. 6, pp. 2259-2259
Open Access | Times Cited: 10
A PRISMA-compliant systematic review and meta-analysis of randomized controlled trials investigating the effects of statin therapy on plasma lipid concentrations in HIV-infected patients
Maciej Banach, Madalina Dinca, Sorin Ursoniu, et al.
Pharmacological Research (2016) Vol. 111, pp. 343-356
Open Access | Times Cited: 22
HIV pharmaceutical care in primary healthcare: Improvement in CD4 count and reduction in drug-related problems
Caroline de Godoi Rezende Costa Molino, Renata Cavalcanti Carnevale, Aline Teotonio Rodrigues, et al.
Saudi Pharmaceutical Journal (2016) Vol. 25, Iss. 5, pp. 724-733
Open Access | Times Cited: 22
Effective prediction of drug – target interaction on HIV using deep graph neural networks
Bihter Daş, Mucahit Kutsal, Resul Daş
Chemometrics and Intelligent Laboratory Systems (2022) Vol. 230, pp. 104676-104676
Closed Access | Times Cited: 11
A review of drug-drug interactions in older HIV-infected patients
Aarthi Chary, Nancy N. Nguyen, Kimberly Maiton, et al.
Expert Review of Clinical Pharmacology (2017) Vol. 10, Iss. 12, pp. 1329-1352
Closed Access | Times Cited: 21
Identification of the Medication Regimen Complexity Index as an Associated Factor of Nonadherence to Antiretroviral Treatment in HIV Positive Patients
M Manzano-García, Concepción Pérez‐Guerrero, Marı́a Álvarez de Sotomayor, et al.
Annals of Pharmacotherapy (2018) Vol. 52, Iss. 9, pp. 862-867
Closed Access | Times Cited: 20
Comprehensive Geriatric Assessment in Older Persons With HIV
Aroonsiri Sangarlangkarn, Jonathan Appelbaum
Open Forum Infectious Diseases (2020) Vol. 7, Iss. 11
Open Access | Times Cited: 15
Drug–Drug Interactions in People Living With HIV at Risk of Hepatic and Renal Impairment: Current Status and Future Perspectives
Nicolas Cottura, Hannah Kinvig, Sandra Grañana‐Castillo, et al.
The Journal of Clinical Pharmacology (2022) Vol. 62, Iss. 7, pp. 835-846
Open Access | Times Cited: 9
Increase in international normalized ratio after switching from atazanavir/ritonavir to darunavir/cobicistat in a patient on warfarin
Alice Tseng, Jonathan Luetkehoelter, Sharon Walmsley
AIDS (2016) Vol. 31, Iss. 1, pp. 175-176
Closed Access | Times Cited: 14
Analysis of drug-drug interactions in patients with HIV and metabolic syndrome
Jessica Tuan, Grace Igiraneza, Onyema Ogbuagu
Expert Opinion on Drug Metabolism & Toxicology (2024), pp. 1-13
Closed Access | Times Cited: 1
A Study to Evaluate Doravirine Pharmacokinetics When Coadministered With Acid‐Reducing Agents
Sauzanne Khalilieh, Ka Lai Yee, Rosa I. Sánchez, et al.
The Journal of Clinical Pharmacology (2019) Vol. 59, Iss. 8, pp. 1093-1098
Closed Access | Times Cited: 10
Older HIV-infected adults: complex patients (III)—polypharmacy
Samuel F. Freedman, Carrie D. Johnston, John J. Faragon, et al.
European Geriatric Medicine (2018) Vol. 10, Iss. 2, pp. 199-211
Open Access | Times Cited: 9
Use of non-antiretroviral drugs among individuals with and without HIV-infection: a Danish nationwide study
Line Dahlerup Rasmussen, Gitte Kronborg, Carsten Schade Larsen, et al.
Infectious Diseases (2016) Vol. 49, Iss. 1, pp. 42-54
Closed Access | Times Cited: 8
Profile of drug–drug interactions and impact on the effectiveness of antiretroviral therapy among patients living with HIV followed at an Infectious Diseases Referral Center in Belo Horizonte, Brazil
Betânia Maira Pontelo, Dirceu Bartolomeu Greco, Nathália Sernizon Guimarães, et al.
The Brazilian Journal of Infectious Diseases (2020) Vol. 24, Iss. 2, pp. 104-109
Open Access | Times Cited: 8
Prevalence of polypharmacy and associated factors among patients living with HIV infection in Spain: The POINT study
Ramón Morillo‐Verdugo, J Sánchez-Rubio-Ferrández, Mercedes Gimeno-Gracia, et al.
Enfermedades Infecciosas y Microbiología Clínica (2020) Vol. 40, Iss. 1, pp. 7-13
Closed Access | Times Cited: 7
Potential Drug-Drug and Drug-Disease interactions of selected experimental therapies used in treating COVID-19 patients
Radhwan Nidal Al-Zidan
Journal of Drug Delivery and Therapeutics (2020) Vol. 10, Iss. 6, pp. 219-230
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top